Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study

BACKGROUND: Recently, many studies have shown that the progress of conversion therapy can provide surgical opportunities for patients with advanced gastric cancer (GC) and bring survival benefits. However, the results of the current study show that the regimen used in conversion therapy is still con...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Ya-Ya, Jiang, Ding-Yi, Zhu, Peng-Fei, Lu, Hongrui, Liu, Qian, Zhang, Xinyue, Pan, Shuang-Yue, Chen, Zhe-Ling, Yang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088230/
https://www.ncbi.nlm.nih.gov/pubmed/37041581
http://dx.doi.org/10.1186/s12957-023-02973-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088230/
https://www.ncbi.nlm.nih.gov/pubmed/37041581
http://dx.doi.org/10.1186/s12957-023-02973-3

Ejemplares similares